4//SEC Filing
Cantley Lewis Clayton Jr. 4
Accession 0001209191-17-060967
CIK 0001439222other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:43 PM ET
Size
16.5 KB
Accession
0001209191-17-060967
Insider Transaction Report
Form 4
Cantley Lewis Clayton Jr.
Director10% Owner
Transactions
- Sale
Common stock
2017-11-13$62.07/sh−1,000$62,070→ 82,394 total - Sale
Common stock
2017-11-13$62.07/sh−1,000$62,070→ 82,434 total(indirect: See footnote) - Sale
Common stock
2017-11-14$59.36/sh−691$41,018→ 81,703 total - Sale
Common stock
2017-11-14$59.36/sh−691$41,018→ 81,743 total(indirect: See footnote) - Sale
Common stock
2017-11-14$60.46/sh−309$18,682→ 81,394 total - Sale
Common stock
2017-11-14$60.46/sh−309$18,682→ 81,434 total(indirect: See footnote)
Holdings
- 20,803(indirect: See footnote)
Common stock
- 20,803(indirect: See footnote)
Common stock
Footnotes (7)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $61.87 to $62.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- [F4]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.05 to $59.71. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.19 to $60.78. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F6]Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
- [F7]Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.
Documents
Issuer
AGIOS PHARMACEUTICALS INC
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001581950
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:43 PM ET
- Size
- 16.5 KB